Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids (Q34304330)

1 August 2017

title

Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids (English)

1 reference

1 August 2017

0 references

Tim Sobolevsky

1

1 reference

1 August 2017

Ilya Prasolov

series ordinal

2

1 reference

1 August 2017

Grigory Rodchenkov

series ordinal

3

1 reference

1 August 2017

publication date

5 October 2012

1 reference

Drug Testing and Analysis

1 August 2017

published in

1 reference

1 August 2017

volume

4

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

745-753

1 reference

Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds

1 August 2017

cites work

1 reference

Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary.

21 January 2018

1 reference

Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system

21 January 2018

1 reference

Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors

21 January 2018

1 reference

Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241,

21 January 2018

1 reference

Chemical analysis of synthetic cannabinoids as designer drugs in herbal products

21 January 2018

1 reference

The emergence and analysis of synthetic cannabinoids

21 January 2018

1 reference

Identification of 1-butyl-3-(1-(4-methyl)naphthoyl)indole in a herbal mixture

21 January 2018

1 reference

Identification and characterization of JWH-122 used as new ingredient in "Spice-like" herbal incenses

21 January 2018

1 reference

Analytical data for identification of the Cannabimimetic Phenylacetylindole JWH-203.

21 January 2018

1 reference

Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.

21 January 2018

1 reference

Synthetic cannabinoids in oral fluid

21 January 2018

1 reference

Detection of JWH-018 metabolites in smoking mixture post-administration urine

21 January 2018

1 reference

Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing

21 January 2018

1 reference

Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites

21 January 2018

1 reference

Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine

21 January 2018

1 reference

The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry.

21 January 2018

1 reference

The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry

21 January 2018

1 reference

Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity

21 January 2018

1 reference

In vitro phase I metabolism of the synthetic cannabimimetic JWH-018

21 January 2018

1 reference

Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS.

21 January 2018

1 reference

Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in ‘herbal incense’

21 January 2018

1 reference

Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples

21 January 2018

1 reference

Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS/MS techniques

21 January 2018

1 reference

Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products

21 January 2018

1 reference

7 January 2021

Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unre

1 reference

7 January 2021

Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry

1 reference

7 January 2021

Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood

1 reference

7 January 2021

Screening for the synthetic cannabinoid JWH‐018 and its major metabolites in human doping controls

1 reference

7 January 2021

Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures

1 reference

7 January 2021

Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures

1 reference

7 January 2021

Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS

1 reference

7 January 2021

Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DTA.1418

1 reference

1 August 2017

1 reference